tiprankstipranks
Trending News
More News >
Solasia Pharma KK (JP:4597)
:4597
Japanese Market

Solasia Pharma KK (4597) Financial Statements

Compare
1 Followers

Solasia Pharma KK Financial Overview

Solasia Pharma KK's market cap is currently ¥7.79B. The company's EPS TTM is ¥-0.62; its P/E ratio is -3.58; Solasia Pharma KK is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue¥ 316.00M¥ 617.00M¥ 1.09B¥ 559.00M¥ 454.00M
Gross Profit¥ 185.00M¥ 337.00M¥ 662.00M¥ 374.00M¥ 245.00M
Operating Income¥ -991.00M¥ -1.14B¥ -2.47B¥ -2.42B¥ -3.31B
EBITDA¥ -1.75B¥ -635.00M¥ -1.94B¥ -1.92B¥ -3.62B
Net Income¥ -1.94B¥ -1.11B¥ -2.55B¥ -2.48B¥ -4.13B
Balance Sheet
Cash & Short-Term Investments¥ 886.00M¥ 728.00M¥ 803.00M¥ 714.00M¥ 2.96B
Total Assets¥ 1.36B¥ 2.23B¥ 3.13B¥ 3.14B¥ 5.78B
Total Debt¥ 25.00M¥ 60.00M¥ 37.00M¥ 84.00M¥ 1.06B
Net Debt¥ -861.00M¥ -668.00M¥ -766.00M¥ -630.00M¥ -1.90B
Total Liabilities¥ 206.00M¥ 354.00M¥ 472.00M¥ 557.00M¥ 2.12B
Stockholders' Equity¥ 1.16B¥ 1.88B¥ 2.66B¥ 2.59B¥ 3.65B
Cash Flow
Free Cash Flow¥ -1.03B¥ -359.00M¥ -2.48B¥ -2.64B¥ -2.96B
Operating Cash Flow¥ -1.03B¥ -359.00M¥ -2.07B¥ -2.47B¥ -2.79B
Investing Cash Flow¥ 0.00¥ 2.00M¥ -418.00M¥ -164.00M¥ -171.00M
Financing Cash Flow¥ 1.18B¥ 275.00M¥ 2.57B¥ 361.00M¥ 1.83B
Currency in JPY

Solasia Pharma KK Earnings and Revenue History

Solasia Pharma KK Debt to Assets

Solasia Pharma KK Cash Flow

Solasia Pharma KK Forecast EPS vs Actual EPS